The prostate cancer section is a comprehensive resource for urology news and expert insights. Read more at Urology Times.

Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.

Panelists discuss how to approach treatment for a younger (49-year-old) male veteran with bladder cancer, focusing on the rising rates among veterans, challenges with recurrent disease despite BCG ...

“We get exposure and get an opportunity to work with experts in the field before we even start fellowship, so that we can develop a baseline of expertise in areas of Peyronie's disease, erectile ...

“The purpose of the course is really to bring together like-minded surgeons and physicians who are interested in robotic reconstructive surgery to really come together to not only build a network, but ...

Key Takeaways Expert panel developed guidelines for onabotulinumtoxinA use in OAB, emphasizing patient experience and compliance. Recommendations cover patient counseling, pre-procedure urinalysis, ...

“Reduced-dose olaparib plus radium-223 resulted in significant improvements in radiographic progression-free survival compared with radium-223 alone. This benefit was most pronounced in those without ...

First-line nivolumab (Opdivo) plus ipilimumab (Yervoy) continued to show improved survival and durable response benefits vs sunitinib (Sutent) in patients with previously untreated advanced renal cell ...

Key Takeaways UGN-102's NDA is supported by the phase 3 ENVISION trial, showing a 79.6% complete response rate at 3 months for LG-IR-NMIBC patients. The FDA is evaluating if the observed duration of ...

In their decision, the committee expressed concerns over a trial design that did not specifically stratify for patients without HRR gene mutations. They also cited concerns over the toxicity of this ...

Key Takeaways The AUSCO trial showed a 94% success rate in achieving significant continence improvement in men with SUI using the artificial urinary sphincter. The study found no device infections and ...

One of many notable highlights from the 2025 American Urological Association Annual Meeting in Las Vegas, Nevada was the release of the “Genitourinary Syndrome of Menopause: AUA/SUFU [Society of ...